explore -WSS

explore

author：Wikipedia 2025-09-30 21:58:10 - browse：5842

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Brain MRIs reveal impact of 'toxic stress' on Black children

WSS

Georgia court denies Trump's request to quash DA's 2020 election probe

Care demand spikes challenge UnitedHealth’s provider arm

Mike Pence clashes with Tucker Carlson in Iowa

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Woman gored by Bison at Yellowstone

Argenx drug significantly slows progression of nerve disorder

knowledge

explore

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

The new HIV moral panic

23andMe had bad news about my health. I wish a person had delivered it

AltruBio raises $225 million to develop ulcerative colitis drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

BIO to announce reorganization, senior leaders expected to depart

Jerome Adams on the need for new antivirals for Covid

The effects of a landmark ruling on DNA ownership are becoming clearer

Guidelines to prevent youth baseball injuries need more muscle

GSK’s asthma push continues as drug succeeds in Phase 3 trials

hotspot

The creative science of coining drug names

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

As health system earnings go up, health insurance stocks go down

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

BIO to announce reorganization, senior leaders expected to depart

Why police arrested suspected Gilgo Beach killer away from his house

focus

Wikipedia

focus

focus